Immucor Puts Up $4M To Settle Price-Fixing Coverup Claims

Law360, Los Angeles (March 6, 2013, 10:26 PM EST) -- Immucor Inc. will pay $3.9 million to settle a securities class action in Georgia federal court accusing the blood-bank instrument maker of defrauding shareholders by covering up a U.S. Department of Justice investigation over a price-fixing scheme, according to a Tuesday motion.

The suit claimed Immucor had artificially inflated its stock price from October 2005 to April 2009 through a scheme with Johnson & Johnson subsidiary Ortho-Clinical Diagnostics Inc. to fix prices for blood reagents. The class action also said Immucor should have disclosed to shareholders...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.